Clinical evidence now supports microplastic reduction as a cardiovascular prevention strategy. Research confirms plastic particles in 58.4% of arterial plaques from heart patients, with those carrying microplastics experiencing 4.5-fold elevated risk of heart attack or stroke. This connection fundamentally reframes environmental health as cardiac health.
Practical implications are emerging for both individuals and public health systems. Reducing single-use plastic consumption—previously an environmental imperative—now represents a measurable cardiac risk mitigation strategy. Patients with existing cardiovascular disease should be counseled on microplastic exposure reduction. Prior studies documented plastic particles circulating in human blood at 1.6 micrograms per milliliter, suggesting ubiquitous exposure. Healthcare providers should consider environmental contamination exposure when assessing individual cardiovascular risk, while policymakers must accelerate regulations limiting microplastic sources in consumer products and water systems.
Read the full article on GMJ Newsroom.
Was this article helpful?
